Navigation Links
Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk
Date:7/31/2014

Toledo, Ohio (PRWEB) July 31, 2014

In a front-page story, the Wall Street Journal (7/30) reports that the pharmaceutical giant, Johnson & Johnson, is withdrawing its laparoscopic power morcellator due to data showing that it can spread undetected cancer. This important story has also been reported by Bloomberg News (7/31), Reuters (7/30), USA Today (7/31), the AP (7/30), the Pittsburgh Business Times (7/30) and TIME (7/30).

The morcellator tool is used during uterine procedures to, “slice up common uterine masses called fibroids, and uteruses themselves, into fragments so they can be removed in minimally invasive surgery.” (Wall Street Journal, 7/30)

J&J previously suspended the sale of new morcellators in April after the U.S. Food and Drug Administration issued a safety communication advising doctors not to use the tool. Specifically, FDA concluded that, “based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.”

The FDA determined that approximately 1 in 350 women who are undergoing hysterectomy or myomectomy for fibroids have an unsuspected type of uterine cancer called uterine sarcoma. It further noted, “If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.”

According to an article published in the Journal of the American Medical Association in March, more than 20,000 minimally invasive or robotic hysterectomies are done annually.

The law firm of Zoll, Kranz & Borgess, LLC (“ZKB”) devotes its practice to the field of pharmaceutical and medical device litigation. ZKB is dedicated to compelling companies to produce safer products. Injured clients and partnering attorneys from across the U.S. appreciate and rely upon over 70 years of combined experience in pharmaceutical mass torts and multidistrict litigation. ZKB’s experienced team includes a practicing physician-attorney and all the technology, knowledge and experience necessary to succeed in this complex legal field.

For more information about morcellators or if you were diagnosed with cancer after a hysterectomy or myomectomy (removal of uterine fibroids) using a power morcellator device, contact ZKB toll-free at (888) 841-9623 or visit the firm’s website at http://www.zkblaw.com. Initial consultations are always free and confidential.

SOURCES
Wall Street Journal (7/30) http://online.wsj.com/articles/johnson-johnson-to-call-for-voluntary-return-of-morcellators-1406754350

FDA News Release (4/17/14)
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm393689.htm

JAMA: Evaluating the Risks of Electric Uterine Morcellation (March 2014)
http://jama.jamanetwork.com/article.aspx?articleid=1828692

Read the full story at http://www.prweb.com/releases/fibroid-hysterectomy/morcellator-cancer-risk/prweb12062687.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study examines presence of uterine cancers at the time of hysterectomy using morcellation
2. Women’s Excellence Physicians Perform Successful Robotic Laparoscopic Hysterectomy to Remove 16 Week-Sized Fibroid Uterus; Small Incisions and Quick Recovery Result
3. Study Says Using the da Vinci Surgical Robot for a Hysterectomy Fails to Cut Complications and May Raise Pneumonia Risk, Notes Parker Waichman LLP
4. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Examining Risks and Benefits of Robotic Surgery Hysterectomy
5. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on New Study Findings that Casts Doubt on Robot-Assisted Hysterectomy
6. Piece of da Vinci Surgical Robot Instrument Breaks off Inside Woman During Hysterectomy; It’s Found Following Months of Suffering, Parker Waichman LLP Notes
7. Johns Hopkins surgeons among the first in the country to perform a robotic single-site hysterectomy
8. Hysterectomy May Not Raise Heart Risks After All: Study
9. Estrogen helps keep joint pain at bay after hysterectomy
10. Robotic Surgery for Hysterectomy Often Not Best Option, Ob/Gyn Group Says
11. Delaying radiation therapy after hysterectomy ups risk of uterine cancer recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... insurance co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy ... prescription medications from over 180 American pharmaceutical companies for $35 per month, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... offering, the Protocol Calendar Exchange , is officially open to all sponsors ... calendars available for sites to download into their clinical trial management system (CTMS), ...
(Date:4/28/2016)... ... 2016 , ... On Thursday, April 14 orthopaedic surgeon ... Institute in Vail, Colorado, attended the American Academy of Orthopaedic Surgeons (AAOS) ... musculoskeletal disorders that are affecting millions of Americans today. Dr. LaPrade and many ...
(Date:4/28/2016)... Valley, California (PRWEB) , ... ... ... Inc. (AGNITY) a leading global provider of intelligent business communication applications and ... and go-live of its Number Portability solution at Bestel’s Communications Network. ...
Breaking Medicine News(10 mins):
(Date:4/26/2016)... CLEVELAND , April 26, 2016 ... is forecast to expand 4.9 percent annually to ... and other healthcare facilities to decrease rates of ... infection prevention supplies, equipment, and services.  Although declining, ... is significantly above targeted levels set by the ...
(Date:4/26/2016)... Bayer AG has reported first-quarter ... and amortization. The earnings are the result of a ... Xarelto and Eylea, drugs Bayer is banking on to ... date was extended by four years this week to ... to reach a value of USD 1,147.1 billion ...
(Date:4/26/2016)... , April 26, 2016 ... Microbial identification Market Size, Share, Development, Growth ... Insights by Product (Consumables, Instruments and Software ... Genotypic Method), by Application (Diagnostic Application, Food ... Application) and by End User (Hospitals, Pharmaceutical ...
Breaking Medicine Technology: